Cargando…
Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
SIMPLE SUMMARY: New therapy options are needed for children with liver cancer. The goal of this study was to evaluate the role of three new compounds in the treatment of liver cancer cells. These compounds all inhibit a protein called Gankyrin, which is known to promote liver cancer by destroying tu...
Autores principales: | D’Souza, Amber M., Gnanamony, Manu, Thomas, Maria, Hanley, Peter, Kanabar, Dipti, de Alarcon, Pedro, Muth, Aaron, Timchenko, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265042/ https://www.ncbi.nlm.nih.gov/pubmed/35804840 http://dx.doi.org/10.3390/cancers14133068 |
Ejemplares similares
-
Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin
por: D’Souza, Amber M., et al.
Publicado: (2021) -
Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation
por: D’Souza, Amber M., et al.
Publicado: (2018) -
Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell
por: Chattopadhyay, Anasuya, et al.
Publicado: (2016) -
Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and Metastasis
por: Luo, Xue, et al.
Publicado: (2012) -
Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma
por: Wang, Chongchong, et al.
Publicado: (2021)